The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Pacific Biosciences of California Inc shares valued at $34,065 were sold by Kim Susan G. on Sep 30 ’24. At $1.72 per share, Kim Susan G. sold 19,782 shares. The insider’s holdings dropped to 695,654 shares worth approximately $1.45 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, SUSAN KIM purchased 19,782 shares, netting a total of over 34,061 in proceeds.
Before that, HENRY CHRISTIAN O had sold 98,907 shares from its account. In a trade valued at $172,692, the insider traded Pacific Biosciences of California Inc shares for $1.75 each. Upon closing the transaction, the insider’s holdings decreased to 98,907 shares, worth approximately $5.2 million.
As published in a research note from UBS on November 11, 2024, Pacific Biosciences of California Inc [PACB] has been rated down from a Buy to a Neutral. As of April 22, 2024, JP Morgan has decreased its “an Overweight” rating to a “Neutral” for PACB. Earlier on April 18, 2024, Goldman downgraded its rating. Their new recommendation was “a Neutral” for PACB stock which previously was a “a Buy”.
Analyzing PACB Stock Performance
During the last five days, there has been a surge of approximately 17.51%. Over the course of the year, Pacific Biosciences of California Inc shares have dropped approximately -78.80%. Shares of the company reached a 52-week high of $9.9900 on 01/02/24 and a 52-week low of $1.1600 on 07/02/24. A 50-day SMA is recorded $1.9200, while a 200-day SMA reached $2.2000. Nevertheless, trading volume fell to 17.71 million shares from 5.96 million shares the previous day.
Support And Resistance Levels for Pacific Biosciences of California Inc (PACB)
According to the 24-hour chart, there is a support level at 1.8700, which, if violated, would cause prices to drop to 1.6700. In the upper region, resistance lies at 2.2100. The next price resistance is at 2.3500. RSI (Relative Strength Index) is 55.65 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.1500, which suggests the price will decrease in the coming days. Percent R is at 9.23%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
